Erlanger Metabolic Center will host its next weight loss seminar on Thursday, May 1, at 5:30 p.m. in Erlanger’s POB Conference Room at the Erlanger Baroness Hospital. The seminar will also be offered ...

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide – a drug known as Zepbound™ – on weight ...

Don’t want to do intense cardio to lose weight? You don’t have to.

The conversation around weight loss has changed dramatically over the past few years. Medications such as semaglutide and tirzepatide—often referred to as GLP-1 therapies—have dominated headlines, ...

Learn why experts advise against stopping and restarting GLP-1 drugs, the health risks of weight yo-yoing, and how to manage long-term weight loss safely.

A Unified Clinical Hub for Metabolic Health The Cloudcure GLP-1 companion platform functions as the central patient interface ...

TIX100 is a specific, orally available TXNIP inhibitor originally developed for its beta-cell protective effects in diabetes. It has received FDA Investigational New Drug approval in diabetes and ...

Center for Weight Loss Surgery explains the differences between duodenal switch and gastric sleeve surgeries for weight loss.

STATEN ISLAND, N.Y. — Richmond University Medical Center’s Bariatric and Metabolic Institute has earned the title of “Blue Distinction Center” by Blue Cross Blue Shield for consistency of quality care ...